logo
Select company
Select metric
-2956.35%Operating Cash Flow Margin
VS
Market
3
Sector
12
Industry
21
History
12
$ 1.3Close
$ 1.09 - $ 16.95 52-Week Range
Ticker Information

Ticker

ERNA

Company Name

ERNEXA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ERNEXA THERAPEUTICS INC - Operating Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ERNA - OCF % Historical data
DateNet Cash Flow - OperationsOperating Cash Flow MarginRevenues
6/30/2025$ -14.43M-2956.35%$ 488K
3/31/2025$ -14.15M-2645.61%$ 535K
12/31/2024$ -15.84M-2720.96%$ 582K
9/30/2024$ -16.95M-2834.78%$ 598K
6/30/2024$ -16.49M-10180.86%$ 162K
3/31/2024$ -18.11M-15744.35%$ 115K
12/31/2023$ -20.41M-30011.76%$ 68K
9/30/2023$ -21.18M-41533.33%$ 51K
6/30/2023$ -21.47M0%$ 0
3/31/2023$ -21.59M0%$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ERNEXA THERAPEUTICS INC's latest trailing twelve months (TTM) OCF % stands at -23.46%.
  • Over the past 5 years, ERNEXA THERAPEUTICS INC's average OCF % has been -8523.83%.
  • The median OCF % for ERNEXA THERAPEUTICS INC during this period was -2720.96%
  • ERNEXA THERAPEUTICS INC reached its highest OCF % over the past 5 years at -23.46%.
  • The lowest OCF % recorded by ERNEXA THERAPEUTICS INC in the same timeframe -41533.33%

ERNEXA THERAPEUTICS INC's OCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

OCF % Benchmarks
CompanyOCF %
BRTX : BIORESTORATIVE THERAPIES INC -1573.04%VYNE : VYNE THERAPEUTICS INC -8355.67%IBIO : IBIO INC -3826%LEXX : LEXARIA BIOSCIENCE CORP -1574.8%LYRA : LYRA THERAPEUTICS INC -5585.32%PULM : PULMATRIX INC -2172.36%APRE : APREA THERAPEUTICS INC -1514.98%HCWB : HCW BIOLOGICS INC -7538.92%MGRX : MANGOCEUTICALS INC -1129.13%PHIO : PHIO PHARMACEUTICALS CORP -

Definition of Operating Cash Flow Margin

[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
CF - Operations / Revenues
(=) OCF %
OCF % for ERNEXA THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -2.3M ] / Revenues [ $ 9.79M ]
(=) OCF % [ -23.46% ]

ERNA - Operating Cash Flow Margin, Last 5 years

-41533.33%

Minimum

Sep 30, 2023

-23.46%

Maximum

Sep 30, 2020

-8523.83%

Average

-2720.96%

Median

OCF % Benchmark Analysis

The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.35% with a standard deviation of 21.14%.
The following table provides additional summary stats:
OCF % in the Market:
filtered constituents3.25K
min-57.27%
max78.12%
average14.35%
median12.67%
std21.14%